logo
India's ban on Jane Street hits options volumes; rebound expected in coming weeks

India's ban on Jane Street hits options volumes; rebound expected in coming weeks

The Indian markets regulator's ban on Wall Street trading giant Jane Street has squeezed volumes in the country's options market, but traders expect activity to snap back as larger investors step in.
The Securities and Exchange Board of India (SEBI) on July 4 barred Jane Street from trading and froze $567 million of its funds for manipulation of stock indexes through derivative positions. Jane Street told staff it plans to challenge the order, calling the trades in question 'basic index arbitrage.'
Since the order, index options premium turnover on the NSE and BSE exchanges declined on a week-on-week basis in four of five sessions.
This metric — representing the total value of premiums paid to buy index options like the Nifty 50 — serves as a key indicator of real capital at play, risk appetite, and overall sentiment in the derivatives market.
While premium turnover rose last Friday, it has fallen in every session this week.
Jane Street to challenge India ban, says it engaged in basic arbitrage
'The ripple effects of the Jane Street episode are expected to linger in the near term, with index options activity showing a noticeable dip as traders reassess risk appetite amid regulatory uncertainty,' said Rajesh Baheti, managing director of Crosseas Capital Services, a Mumbai-based proprietary trading firm.
Baheti said this may be temporary.
'If proprietary trading firms regain confidence in market transparency and regulatory clarity, activity could rebound meaningfully within four to six weeks,' he said.
Proprietary traders have largely stayed on the sidelines since the ban, reflected in persistently low volumes, with both turnover and the number of unique clients in the derivatives segment declining, two analysts said.
'The dip in index options activity reflects growing market jitters, triggered by the Jane Street ban, global tensions, and shifting trade policies,' said Shitij Gandhi, senior research analyst - technicals at SMC Global Securities.
Options market activity may have also declined due to a delay in U.S. President Donald Trump's tariff deadline to August 1, which prompted market participants to pull back on aggressive hedging.
Lower volumes on bank nifty
Jane Street, SEBI says, traded most aggressively in derivatives linked to the Bank Nifty index and its 12 constituent stocks.
The Wall Street trader's exit from the market has also pulled down trading volumes in these stocks.
Aggregate trading volumes in the Nifty Bank index have halved in five sessions ending Thursday, dropping to 495.75 million shares from 1.02 billion shares in the five sessions preceding the ban.
'In the very near term, some dent in trading activity is inevitable since Jane Street was a dominant force in derivatives, but this saga alone can't explain the drop in Bank Nifty volumes,' said Kranthi Bathini, director of equity strategy at WealthMills Securities.
'Once the global markets stabilise and trade worries ease, volumes are likely to bounce back,' Bathini said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nvidia to resume China chip sales amid shifting US export policy
Nvidia to resume China chip sales amid shifting US export policy

Express Tribune

timean hour ago

  • Express Tribune

Nvidia to resume China chip sales amid shifting US export policy

Nvidia has confirmed it is filing applications to restart sales of its H20 artificial intelligence chips to China, following months of shifting US export rules. The move, confirmed through a blog post on Nvidia's website, comes after the Trump administration reversed restrictions imposed earlier this year, opening the door for resumed trade. The company expects to secure US government licences soon and begin deliveries shortly after. It has also announced a new chip, the 'RTX Pro,' designed specifically for the Chinese market and said to comply fully with current export regulations. Nvidia describes the chip as optimised for digital manufacturing, including logistics and smart factory systems. Though not its most advanced processor, the H20 is the most powerful chip Nvidia can legally sell to China under existing rules. Built for inference tasks (the operation of trained AI models) the chip is favoured for its superior memory bandwidth and seamless integration with Nvidia's established software ecosystem. The company's stock also skyrocketed, surging to a new record after the announcement was made. BREAKING: Nvidia stock, $NVDA, surges to a record $170/share in overnight trading after announcing H20 chip sales to China will resume. Nvidia also announces a fully compliant GPU for China. This company just keeps on evolving. — The Kobeissi Letter (@KobeissiLetter) July 15, 2025 Chinese technology firms including ByteDance, Alibaba and Tencent had stockpiled the H20 in early 2025 amid fears of impending restrictions, according to GuruFocus. The chip's popularity, coupled with its performance, meant Nvidia stood to lose as much as $16 billion in revenue when the initial ban was enforced in April. The reversal came weeks after Nvidia CEO Jensen Huang attended a $1 million-per-seat fundraising dinner at former President Donald Trump's Mar-a-Lago resort. According to NPR, the White House softened its stance following Huang's commitment to invest heavily in US-based infrastructure. Nvidia subsequently announced a plan to build domestic AI data centres worth up to $500 billion over four years, in partnership with TSMC. Critics in Washington have questioned the consistency of US policy, warning that easing restrictions could erode efforts to limit China's AI capabilities. Concerns have grown following breakthroughs by Chinese startups like DeepSeek, which trained an advanced AI model earlier this year using Nvidia's H800 chips — a product banned since 2023 but still reportedly reaching China through alternative channels. In the blog post, Nvidia spokesperson Hector Marinez said Huang had been engaging with officials in both Washington and Beijing to highlight the benefits of AI for industry and society. The episode illustrates the competing pressures facing US policymakers as they navigate national security concerns and economic interests. With geopolitical tensions continuing to shape the tech landscape, further shifts in policy appear likely.

Pakistan's Zarea sets up subsidiary in Dubai to drive global expansion
Pakistan's Zarea sets up subsidiary in Dubai to drive global expansion

Business Recorder

time2 hours ago

  • Business Recorder

Pakistan's Zarea sets up subsidiary in Dubai to drive global expansion

Zarea Limited, one of Pakistan's largest commodities B2B platforms, has taken a key step towards global expansion with the successful incorporation of a wholly owned subsidiary in Dubai, United Arab Emirates (UAE). The listed company disclosed the development in its notice to the Pakistan Stock Exchange (PSX) on Tuesday. 'We are pleased to inform you that pursuant to the approval of the Board of Directors of Zarea Limited the company has successfully incorporated a wholly owned subsidiary in the UAE under the name ZAREA COMMERCE FZCO,' read the notice. Zarea said the incorporation of this UAE-based entity marks a major milestone in the company's global expansion strategy. 'With the launch of our regional headquarters in Dubai, Zarea is now well-positioned to expand into international markets and strengthen its role in technology-driven B2B trade. 'This initiative is a cornerstone of our long-term growth strategy—expanding our global footprint, strengthening overseas operations, accelerating export-led growth, digitising trade, and unlocking new markets worldwide,' it said. Zarea remains confident that the strategic investment will accelerate its long-term growth trajectory and generate sustained value for its shareholders. Earlier this year, the B2B commerce platform raised Rs1.03 billion by selling 62.5 million shares in the 2025 first initial public offering (IPO) at the PSX. Back then, Zarea said that the IPO proceeds would be strategically deployed to drive its continued expansion and operational efficiency. A significant portion of the working capital will be invested in Agri Biomass, a rapidly growing sector as businesses increasingly adopt renewable and sustainable energy solutions. Additionally, 24% of the proceeds will be utilised to establish an in-house logistics model, allowing Zarea to transition away from third-party logistics providers. Furthermore, 12% of the proceeds will be directed toward technology upgrades to ensure scalability and enhance the customer experience. The remaining funds will be allocated to marketing, human resources, and office expansion.

Indian drugmaker Anthem Biosciences' $395 million IPO fully subscribed on day two
Indian drugmaker Anthem Biosciences' $395 million IPO fully subscribed on day two

Business Recorder

time3 hours ago

  • Business Recorder

Indian drugmaker Anthem Biosciences' $395 million IPO fully subscribed on day two

Indian drugmaker Anthem Biosciences' $395 million public listing was fully subscribed on the second day of bidding, as investors bet on the company's growth prospects at a time when global big pharma are turning to India to limit their reliance on China. The IPO received bids worth 26.38 billion rupees ($307 million), or 1.05 times the shares on offer as of 10:24 a.m. IST, exchange data showed on Tuesday. The shares are likely to start trading on July 21. Global drugmakers have been seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trialsand early-stage manufacturing, a move that is benefiting rivals in India. Anthem, which began operations in 2007 and has two manufacturing facilities in Bengaluru, offers early-stage drugdiscovery and drug efficacy testing. It also makes active pharmaceutical ingredients, the main component of a drug, as well as dietary supplements and probiotics. India markets regulator approves WeWork franchisee's IPO The drugmaker raised $118 million from anchor investors last week, including from Abu Dhabi Investment Authority, Norway's Norges Bank and France's Societe Generale, as well as domestic funds such as HDFC Mutual Fund and ICICI Prudential AMC. Indian firms are expected to raise $2.4 billion through public issues in July, raising hopes of a sustained revival in primary offerings after demand was dented by the U.S. trade war and global geopolitical tensions earlier this year. Private equity firm True North and drugmaker DavosPharma were among the investors who sold shares in the IPO. Anthem did not sell any shares.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store